X4 Pharmaceuticals (XFOR) Other Accumulated Expenses (2017 - 2019)

X4 Pharmaceuticals has reported Other Accumulated Expenses for 3 years, with the latest figure at $280000.0 in Q2 2019.

• For the quarter ending Q2 2019, Other Accumulated Expenses fell 36.65% year-over-year to $280000.0; the trailing twelve-month figure through Jun 2019 stood at $280000.0 (down 36.65% YoY), and the FY2018 full-year result was $249000.0, down 50.0% from the prior year.
• Other Accumulated Expenses for Q2 2019 stood at $280000.0, up from $271000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $498000.0 in Q4 2017, with the low at $249000.0 in Q4 2018.
• Historically, Other Accumulated Expenses has averaged $361857.1 across 3 years, with a median of $386000.0 in 2018.
• Annual changes were most pronounced in 2018 — Other Accumulated Expenses sank 50.0% — and 2019, when it plunged 33.42%.
• X4 Pharmaceuticals' Other Accumulated Expenses stood at $498000.0 in 2017, then slumped by 50.0% to $249000.0 in 2018, then increased by 12.45% to $280000.0 in 2019.
• The last three Other Accumulated Expenses figures came in at $280000.0 (Q2 2019), $271000.0 (Q1 2019), and $249000.0 (Q4 2018), per Business Quant data.